American Society for Reproductive Medicine

View all recommendations from this society

March 3, 2022

Don’t use tests of ovarian reserve (oocyte quantity measures such as AMH or FSH levels) to judge a woman’s reproductive potential (whether someone is likely or unlikely to become pregnant).

Markers of ovarian reserve, such as early follicular phase FSH or antimüllerian hormone (AMH) levels, have been shown to be poor independent predictors of reproductive potential. Therefore, they should not be used as a “fertility test” for women who are not infertile or who have untested fertility.


These items are provided solely for informational purposes and are not intended as a substitute for consultation with a medical professional. Patients with any specific questions about the items on this list or their individual situation should consult their physician.

How The List Was Created

The Practice Committee of the American Society for Reproductive Medicine (ASRM) reviewed evidence from ASRM’s practice documents to identify possible topics along with suggestions for possible topics from the ASRM Board of Directors. By consensus, the Practice Committee narrowed the list to the top five most overused tests within specified parameters. Additional input was sought from the ASRM Board of Directors and incorporated. The final list was reviewed and approved by the ASRM Board of Directors. The ASRM Board of Directors and Practice Committee are comprised of representatives from every aspect of reproductive medicine through our five affiliated societies including the Society for Assisted Reproductive Technology, the Society of Reproductive Surgeons, the Society for Reproductive Endocrinology and Infertility, the Society for Male Reproduction and Urology and the Society of Reproductive Biologists and Technologists.

ASRM’s disclosure and conflict of interest policy can be found at www.asrm.org.

Sources

Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020 Dec;114(6):1151-1157